BNP Paribas Financial Markets’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $76.2K | Sell |
16,310
-328,578
| -95% | -$1.53M | ﹤0.01% | 3293 |
|
|
2025
Q1 | $1.89M | Buy |
344,888
+244,876
| +245% | +$1.34M | ﹤0.01% | 1716 |
|
|
2024
Q4 | $339K | Buy |
+100,012
| New | +$339K | ﹤0.01% | 2728 |
|
|
2021
Q4 | – | Sell |
-1,118
| Closed | -$2.74K | – | 3587 |
|
|
2021
Q3 | $2.74K | Sell |
1,118
-700
| -39% | -$1.72K | ﹤0.01% | 3159 |
|
|
2021
Q2 | $7.4K | Sell |
1,818
-4,182
| -70% | -$17K | ﹤0.01% | 3175 |
|
|
2021
Q1 | $27.1K | Sell |
6,000
-3,150
| -34% | -$14.2K | ﹤0.01% | 3148 |
|
|
2020
Q4 | $45K | Sell |
9,150
-1,935
| -17% | -$9.52K | ﹤0.01% | 2951 |
|
|
2020
Q3 | $65.7K | Buy |
11,085
+8,181
| +282% | +$48.5K | ﹤0.01% | 2718 |
|
|
2020
Q2 | $7.73K | Sell |
2,904
-6,330
| -69% | -$16.8K | ﹤0.01% | 3191 |
|
|
2020
Q1 | $18K | Buy |
9,234
+6,162
| +201% | +$12K | ﹤0.01% | 3313 |
|
|
2019
Q4 | $21.7K | Sell |
3,072
-483
| -14% | -$3.41K | ﹤0.01% | 3308 |
|
|
2019
Q3 | $34.9K | Buy |
3,555
+1,242
| +54% | +$12.2K | ﹤0.01% | 3041 |
|
|
2019
Q2 | $26.5K | Sell |
2,313
-1,974
| -46% | -$22.6K | ﹤0.01% | 3171 |
|
|
2019
Q1 | $43K | Buy |
+4,287
| New | +$43K | ﹤0.01% | 2998 |
|